definiens: . 1.26 shall mean all amounts and other consideration received by Predix or an Affiliate of Predix, in connection with a Sublicense, excluding loans given at prevailing mar ket conditions, research funding specifically committed to cover costs [ * * * * * * ] incurred by Predix in the research and development of Licensed Products under and in accordance with [ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ] bona - fide subl icense agreements with Sublicensees [ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ] and equity investments in Predix [ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ] ; provided that in the event that Predix or an Affili ate of Predix receives non - monetary consideration in connection with any s uch Sublicense or in the case of transactions not at arm 's length, Sublicense Inc ome shall be calculated based on the fair market value of such consideration or t ransaction, assuming an arm 's length transaction made in the ordinary course of b usiness